Zobrazeno 1 - 10
of 33
pro vyhledávání: '"R. M. Mcmillan"'
Publikováno v:
ChemInform. 22
Since the hypothetical mechanisms of hydroperoxydation of arachidonic acid by, respectively, 5-lipoxygenase (5-LPO) and cyclooxygenase (CO) involve a redox cycle, a compound which reduces 5-LPO and CO to their inactive state would give a nonselective
Autor:
Graham Charles Crawley, S. J. Foster, P. Bruneau, M. P. Edwards, R. M. Mcmillan, J. F. Kingston, T. G. C. Bird, J.-M. Girodeau
Publikováno v:
ChemInform. 22
Autor:
R. M. McMillan, K. E. Proudman
Publikováno v:
Agents and Actions. 34:121-124
Tolfenamic acid and tenidap have been reported to be dual inhibitors of cyclo-oxygenase and 5-lipoxygenase. In this study inhibition of 5-lipoxygenase by tenidap and tolfenamic acid in plasma-free leukocyte suspensions (IC50 values = 10 microM) requi
Autor:
M. P. Edwards, S. J. Foster, J. F. Kingston, R. M. Mcmillan, J.-M. Girodeau, T. G. C. Bird, G. C. Crawley
Publikováno v:
Agents and Actions. 34:110-112
Methoxyalkyl thiazoles are novel 5-lipoxygenase inhibitors which are neither redox agents nor iron chelators and are exemplified by ICI211965 [1-(3-(naphth-2-ylmethoxy)phenyl)-1-(thiazol-2-yl)prop yl methyl ether]. ICI211965 potently inhibits LTC4 sy
Publikováno v:
British Journal of Pharmacology. 101:501-503
The studies described here, using enantiomers of an optically-active methoxy alkyl thiazole ICI216800 (1-methoxy-6-(naphth-2-yl-methoxyl)-1- (thiazol-2-yl)indane), provide unequivocal evidence for a specific, chiral interaction with 5-lipoxygenase. I
Publikováno v:
Mechanisms and Models in Rheumatoid Arthritis
This chapter reviews several potential approaches for novel therapies, based on modulation of the arachidonic acid metabolites. It describes two approaches for discovering drugs with the efficacy, but not the side-effects, of non steroidal anti-infla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e629895f9f0a1e748153071ee65be33c
https://doi.org/10.1016/b978-012340440-4/50046-5
https://doi.org/10.1016/b978-012340440-4/50046-5
Autor:
G C, Crawley, T G, Bird, P, Bruneau, R I, Dowell, P N, Edwards, S J, Foster, J M, Girodeau, R M, McMillan, E R, Walker, D, Waterson
Publikováno v:
Journal of lipid mediators. 6(1-3)
Structure and activity relationships of (methoxyalkyl)thiazole and 4-methoxytetrahydropyran series of 5-lipoxygenase inhibitors are reviewed. One member of the 4-methoxytetrahydropyran series, 6-([fluoro-5-(4-methoxy-3,4,5,6-tetrahydro-2H-pyran-4-yl)
Publikováno v:
Journal of leukocyte biology. 53(2)
Human polymorphonuclear leukocytes (PMNs) stimulated by N-formylmethionyl-leucyl- phenylalanine (fMLP), leukotriene B4 (LTB4) and platelet-activating factor (PAF) showed a similar sequence of ultrastructural changes. Exposure of unstirred PMNs to die
Autor:
J.-M. Girodeau, David Waterson, R. I. Dowell, R. M. Mcmillan, S. J. Foster, E. R. H. Walker, P. N. Edwards, Graham Charles Crawley, P. Bruneau, T. G. C. Bird
Publikováno v:
ChemInform. 23
Autor:
R. M. Mcmillan, Pierre Andre Raymond Bruneau, John F. Kingston, T. Geoffrey C. Bird, Graham Charles Crawley, Martin Paul Edwards, Jean Marc Girodeau, S. J. Foster
Publikováno v:
Journal of medicinal chemistry. 34(7)
(Methoxyalkyl)thiazoles are novel 5-lipoxygenase (5-LPO) inhibitors that are neither redox agents nor iron chelators. Consideration of a hypothetical model of the enzyme active site led to this series which is exemplified by 1-[3-(naphth-2-ylmethoxy)